Home » Topics » Conferences

Conferences
RSS

Modifications to the linezolid molecule a focus of research at Pharmacia & Upjohn

Sep. 28, 1998

UCB's anticonvulsant drug levetiracetam is safe and effective in phase III trials

Sep. 28, 1998

P&U explores modifications to linezolid; new, more active oxazolidinones result

Sep. 25, 1998

Zanamivir results presented at ICAAC; two more regulatory filings announced

Sep. 25, 1998

In vitro and in vivo activity of S-34109 against Chlamydia and MRSA

Sep. 25, 1998

IB-643 more effective than AmB in treating systemic murine candidosis

Sep. 25, 1998

Profile of activity of new antifungal antibiotic presented by Fujisawa at ICAAC

Sep. 25, 1998

Administration of multiple high doses of S-4661 does not affect safety, pharmacokinetics

Sep. 25, 1998

KRM-1648 combinations show strong, rapid and long-lasting antimycobacterial activity

Sep. 25, 1998

Head-to-head comparison of two HBV vaccines

Sep. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...